SPY441.40-4.34 -0.97%
DIA345.64-1.80 -0.52%
IXIC15,043.97-137.96 -0.91%

Revance Highlights Publication Of Results On Static Glabellar Lines With Repeated Treatment Of DaxibotulinumtoxinA For Injection From The SAKURA Clinical Program In Dermatologic Surgery

- Post-hoc analysis demonstrates sustained improvement of static glabellar lines with repeated treatment of DaxibotulinumtoxinA for Injection - Results suggest that the extended duration of therapeutic benefit

Post-hoc analysis demonstrates sustained improvement of static glabellar lines with repeated treatment of DaxibotulinumtoxinA for Injection - Results suggest that the extended duration of therapeutic benefit · 09/01/2021 08:05